Yes, but pair the product choice with process discipline: endotoxin-controlled reagents, consistent recovery time, and standardized plating. Include baseline and vehicle controls on every plate, and consider adding an early time point to detect any handling-induced activation before drug exposure.
With proper thaw and recovery, robustness should remain strong. The largest determinant of yield is temperature stability and gentle processing. Avoid "extra washes" unless needed; each step can reduce recovery and increase stress.
Differentiate the full vial in a controlled run, then cryopreserve macrophages in assay-sized aliquots (if your protocol supports it) so downstream experiments stay donor-consistent. Validate phenotype after re-thaw before scaling this strategy.
For Research Use Only. Do Not Use in Food Manufacturing or Medical Procedures (Diagnostics or Therapeutics). Do Not Use in Humans.